Clinical Research Directory
Browse clinical research sites, groups, and studies.
OssiMend BA in Posterolateral Instrumented Lumbar Fusion
Sponsor: Collagen Matrix
Summary
The primary objective of this study is to measure the success rate of lumbar fusion in subjects at 12 months when instrumented lumbar arthrodesis is performed using OssiMend Bioactive Moldable as the bone grafting material
Official title: OssiMend Bioactive Moldable in Posterolateral Instrumented Lumbar Fusion
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2021-01-21
Completion Date
2027-01-30
Last Updated
2025-10-16
Healthy Volunteers
No
Conditions
Interventions
OssiMend™ Bioactive Moldable
Lumbar Spine fusion with OssiMend™ Bioactive Moldable
Locations (4)
San Diego Neurosurgery
Encinitas, California, United States
Hartford Hospital
Hartford, Connecticut, United States
University Orthopaedic Associates, Division of OrthoNJ
Somerset, New Jersey, United States
McKenzie-willamette Medical Center
Eugene, Oregon, United States